Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors
Article in The Journal of Pathology Clinical Research (January 2024)
The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.
Article in The Journal of Pathology Clinical Research (January 2024)
Article in International Journal of Molecular Sciences (September 2023)
Article in Research (January 2023)